% | $
Quotes you view appear here for quick access.

Inovio Pharmaceuticals, Inc. Message Board

miamigent1 745 posts  |  Last Activity: Jun 6, 2016 11:40 AM Member since: May 18, 2013
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • OXM ER Play for AMC Tuesday

    JUN 7 OXM to announce Q1 earnings After Market (Confirmed)

    Oxford Industries, Inc. is a clothing retailer in the United States that specializes in high-end clothing and apparel. The company carries many major labels, including Tommy Bahama, Lilly Pulitzer, Southern Tide, Oxford Golf and Lanier Clothes.

  • HDS ER Play for BMO Tuesday

    JUN 7 HDS to announce Q1 earnings Before Market (Confirmed)

    HD Supply is an industrial distributor in North America. The company provides a broad range of products and value-added services to approximately 500,000 professional customers in maintenance, repair and operations, infrastructure and power and specialty construction sectors.

  • CASY ER Play for AMC Monday

    JUN 6 CASY to announce Q4 earnings After Market (Confirmed)

    Casey's General Stores, Inc., is a chain of convenience stores in the Midwestern United States, primarily within the states of Iowa, Illinois, Indiana, Missouri, South Dakota, North Dakota, Minnesota, Kansas, Oklahoma, and Nebraska.

  • COO ER Play for AMC today

    Slim picken's but may give some milk..

    Will need to swing to Bounce Plays now that ER Season grinding down


  • ER Play for Mon bef mkt open VRTU

    Presently at 35.16

    Small SS

    MAY 16 VRTU to announce Q4 earnings Before Market (Confirmed)

  • Reply to

    M&A for Tyson? Butterball Turkey?

    by snogreen Mar 1, 2016 12:10 PM
    miamigent1 miamigent1 May 7, 2016 9:43 AM Flag

    Very good analysis, snogreen.

  • At 7.89 PPS above Goldman PT raise today to 7.50
    Low float walk-up.
    Added to short- company can't cut its way to growth. Biz model doesn't work.
    ER was lipstick on a pig.

  • miamigent1 miamigent1 Apr 17, 2016 10:30 PM Flag

    Yup, she is a congenital liar.

    Please find us a suitable women for President to support.

  • Reply to

    BTU Six Of Last Seven Days Were Advances

    by miamigent1 Mar 24, 2016 4:22 PM
    miamigent1 miamigent1 Mar 26, 2016 6:43 AM Flag

    (reprint from another MB) " ..Your reply fails to acknowledge my just previous point that a Buyer now may get exactly what they want, uncrowded by competing bids and the prompt, all cash requirement typical of BK court. Further, your reply assumes BK which is not known at this time. "Going Concern" notices go out frequently without coming to fruition.
    Good luck with your future investments.

    Folks, this is a wild play, certainly not for anyone other than speculators who have been around the block a few times. No one should have grocery money in this- word. But for those in, be aware of sweeping declarations of what's going to happen, as if fact. None of us know except I noted in the low 2's that the risk reward ratio was enticing for a lotto size bet.


  • BTU Got a little ahead of itself Tuesday close so a breather yesterday.
    Today, back on its bicycle to close up (2.56)
    Six of last seven days have been advances
    Any news of BTU doing a deal with Bowie or other and it's "to the moon, Alice!"
    Prudent shorts covering some to lock in sure profits, pass on possible lunar landing.

  • miamigent1 by miamigent1 Mar 16, 2016 6:43 PM Flag

    BTU turned up at close on good vol. Presently up .05 in AH at 2.24.

  • Reply to

    VRX Negative Bloomberg Article Out This Morning

    by miamigent1 Oct 29, 2015 6:56 AM
    miamigent1 miamigent1 Oct 29, 2015 7:20 AM Flag

    Bloomberg Article part 3.

    Valeant also said, on the Oct. 26 call, that sales hadn’t been artificially inflated because it consolidates Philidor’s results on its own books and doesn’t record those sales until prescriptions are shipped to patients.

    It said it didn’t have to declare its interest in Philidor because the specialty pharmacy network has accounted for about 6 percent of Valeant revenue so far this year. That is below the 10 percent sales threshold that would make the arrangement material under Generally Accepted Accounting Principles, the company said in its presentation.

    Valeant declined to provide additional comment. It has called R&O’s payment-dispute lawsuit “without merit” and said it will file a counterclaim.

    Philidor referred requests for comment to public-relations firm Hill & Knowlton, which declined to comment, citing pending lawsuits. Lawyers for Isolani didn’t respond to requests for comment.

    Isolani alleged in its California suit that Reitz and his pharmacy were withholding drug reimbursements that weren’t theirs, and that Reitz had breached his contractual obligations while Isolani had upheld theirs. Philidor, which is mentioned in e-mails and documents filed as part of that suit, isn’t a party.

    Reitz’s lawyer, Gary Jay Kaufman, declined to comment via e-mail.

  • The Tiny Pharmacy at the Center of Valeant's Money Mystery

    Robert Langreth
    t RobertLangreth

    October 29, 2015 — 5:00 AM EDT

    After agreeing to sell his pharmacy, owner's questions mounted

    Long before investors directed a barrage of scrutiny at Valeant Pharmaceuticals International Inc., one Southern California pharmacist began pulling on a thread.

    Valeant disclosed last week that it had ties to a network of pharmacies filling prescriptions for its drugs across the U.S., setting off a $10 billion drop in its market value as investors struggled to reassess the company’s sales picture. Asked why it hadn’t talked sooner about the related web of pharmacies, Valeant said that it hadn’t been bound to do so.

    But the company has had little option but to explain itself in the past week thanks to a growing chorus of questions -- among the first of which came from R&O Pharmacy, a smoked-glass storefront amid rows of low-slung office buildings in Camarillo, California.

    Less than a year ago, 64-year-old pharmacist Russell Reitz agreed to sell his business there to a Delaware-registered company for $350,000. R&O soon became the victim of widespread fraud, Reitz’s lawyer alleged in documents filed in a billing suit against him in state court in California.

    Even before the sale agreement was executed, other pharmacies began using an R&O identification number to bill for prescriptions that R&O hadn’t filled, sometimes for drugs the store...

  • Reply to

    Question for Investguy571

    by magalo555 Oct 16, 2015 6:08 PM
    miamigent1 miamigent1 Oct 17, 2015 2:24 PM Flag

    With you. You even could have said, "O 'Reilly's ghost written books.

  • Reply to

    Question for Investguy571

    by magalo555 Oct 16, 2015 6:08 PM
    miamigent1 miamigent1 Oct 17, 2015 12:14 PM Flag


  • Reply to

    Sltock Market

    by richa58 Oct 14, 2015 5:47 PM
    miamigent1 miamigent1 Oct 14, 2015 7:53 PM Flag

    Totally agree- PPS direction today was not reflective of the Q report.

  • miamigent1 miamigent1 Oct 13, 2015 8:38 PM Flag

    HAWK CFO Jerry Ulrich added, "Adjusted EBITDA grew 95%, higher than adjusted operating revenue growth due to leverage in sales and marketing, and general and administrative expenses. Excluding the reduction in cash taxes payable related to our 2014 spin-off from Safeway and the realization of acquisition-related net operating losses, adjusted net income grew 107% and adjusted diluted EPS grew 89% during the third quarter. Further, excluding 2014 and 2015 acquisitions, adjusted operating revenues grew 22% and adjusted EBITDA grew 49%."

  • HAWK Blackhawk Announces Third Quarter 2015 Financial Results; Adjusted Operating Revenues Rise 54% Versus Third Quarter 2014; Adjusted Net Income Increases 59%

    BY GlobeNewswire — 5:00 PM ET 10/13/2015

    PLEASANTON, Calif., Oct. 13, 2015 (GLOBE NEWSWIRE) -- Blackhawk Network Holdings, Inc. (HAWK) today announced financial results for the third quarter ended September 12, 2015.

    $ in millions except per share amounts Q3'15 Q3'14 % Change

    Adjusted Operating Revenues $ 193.4 $ 125.4 54%
    Adjusted EBITDA $ 28.6 $ 14.7 95%
    Adjusted Net Income $ 19.8 $ 12.4 59%
    Adjusted EPS (Diluted) $ 0.35 $ 0.23 52%
    Operating Revenues (GAAP) $ 352.7 $ 269.0 31%

  • Reply to

    7.30 Pivot?

    by miamigent1 Oct 12, 2015 10:56 AM
    miamigent1 miamigent1 Oct 12, 2015 11:04 AM Flag

    EOD is what counts and I'll venture green.
    'Tutes want in- they took it down, now they have to load.

  • miamigent1 by miamigent1 Oct 12, 2015 10:56 AM Flag

    PACB 7.30 may be the pivot. Sell off could be finishing..

    We'll see

9.646+0.056(+0.58%)2:56 PMEDT